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INTRODUCTION
Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease with individual variation of organ involvement (e.g., skin, joints, kidneys, nervous system and serous membranes) (1) . Disease activity often varies over time and subjective symptoms are described as being prominent (2, 3) . Both clinical care and research assessments are traditionally focused on predefined aspects of SLE (e.g., selected symptoms or aspects of disease impact) in which patients are asked to rate or assess different parameters according to chosen standards. When SLE disease activity and manifestation are assessed, the focus is often on objective signs and symptoms traditionally observed by physicians. There are however indications that several concepts of importance to patients (e.g. subjective symptoms) are not adequately captured by recommended measures of disease activity and health status (4, 5) . This insight has contributed to today's recommendation to incorporate patient-reported outcomes in research (6) in an effort to cover disease activity and impact more fully. In recent years a number of studies have sought to gain a better understanding of the aspects of living with SLE by involving the patient's perspective and thus identify variations in the experience of SLE and disease-related symptoms. One example of this approach is the development of a SLE Specific Symptom Checklist (7-9), as well as other procedures used to identify disease-driven health issues identified by patients (10) .
To understand the consequences of patient-reported symptoms on disease impact data from health-related quality of life (HRQoL) questionnaires can be used. HRQoL includes several dimensions, physical as well as psychological, and represents a broad perspective of the overall impact of disease. HRQoL is an important complement to measures of disease activity and damage (11) (12) (13) . For instance, comparative studies have shown that patients with SLE 5 perceive reduced HRQoL compared with controls and in parity with several other diseases (14) (15) (16) (17) (18) (19) .
How the broad spectrum of SLE symptoms affects patients' experience of HRQoL is not yet well understood. Different methods, as focus-groups and Delphi studies, have been used to capture aspects of SLE that are important to the patients (4, 20) . Stamm et al (4) explored if important concepts of daily functioning per se are represented in the HRQoL and Bauernfeind et al (20) how important concepts could be identified by International Classification of Function (ICF). These studies did not explore if these concepts represent differences in selfreported HRQoL.
To contribute to the understanding of patients' experience of SLE we aimed to explore the spontaneously most distressing symptoms of systemic lupus erythematosus (SLE) and to determine how these symptoms relate to HRQoL, anxiety/depression, patient characteristics (age, partner status) and disease characteristics (duration, activity and organ damage).
PATIENTS AND METHODS
The present study is part of an ongoing cohort project started in 2004 at Karolinska University Hospital Solna, where all patients with SLE have consecutively received an information letter and given the opportunity to participate. The patients gave their written consent in a replypaid envelope. Patients included in the cohort study from January 2004 to March 2010 were consecutively and continuously included in the present study. All patients were 18 years of age or older, Swedish speaking and writing, and fulfilled the American College of Rheumatology (ACR) 1982 revised criteria for SLE (≥4 ACR criteria) (21) . Exclusion criteria 6 were difficulties to read and write Swedish. The study was approved by the regional ethical review board.
At the study inclusion, the participants gave written answers to two open questions ("What SLE-related symptoms have you experienced as most difficult during your disease?" and "What symptoms do you presently perceive as most difficult?"). The patients also completed self-assessment measures of HRQoL, anxiety and depression (see below). These selfassessments were followed by a physical examination, assessment of disease manifestations, activity and organ damage, all of which were performed by a rheumatologist. The Hospital Anxiety and Depression Scale (HADS) (23, 24) consists of 14 items, equally divided into two scales (an anxiety scale and a depression scale). The range for each scale is 0-21: the cut-off for normal values is described to be 7. According to standard protocol, the respondents were requested to answer each item based on their feelings during the past week.
Disease-specific measures. At the inclusion visit, the physicians performed all the diseasespecific assessments. Two instruments were used to assess disease activity: the Systemic Lupus Activity Measure (SLAM) (25, 26) and the SLE disease activity index (SLEDAI) (27) .
The SLAM covers clinical symptoms during the past month, including laboratory parameters, organ manifestations and some subjective symptoms such as fatigue and headache. It is divided into nine areas (score range 0-86, with high values representing a higher level of activity). SLEDAI includes 24 items corresponding to nine organ systems (score range 0-105). We chose to use both of these two frequently used instruments due to indications that SLAM is more sensitive to changes important to patients (28) but SLEDAI is more frequently used.
To assess cumulative organ damage the Systemic Lupus International Collaboration Clinics/American College of Rheumatology (SLICC/ACR) damage index was used. This index includes 12 organ systems with scores ranging from 0 to 47 (29, 30) .
Data analysis.
The study used a mixed method approach representing of data from free written answers as well as standardized questionnaires. The data collection of the written answers were inspired from the free-listing methods originally used in anthropology and also used and described in oncology in the collection of patient reported symptoms from persons with e.g. lung cancer (31) 
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To explore the symptom categories comparisons were conducted between reporters (patients with a written statement in a specific symptom category) and non-reporters (patients reporting any other symptom but not the specific symptom investigated) within the symptom categories using the Mann-Whitney U test.
The collected quantitative data were mostly categorical, nominal or ordinal and therefore nonparametric tests were used. Medians with interquartile ranges (IQRs) are presented for numerical data and percent is used for frequency data. The quantitative data from the questionnaires were analyzed using the Statistical Package for the Social Sciences (SPSS, Chicago IL, USA), version 15.
RESULTS

Participants.
This study included a total of 324 patients with SLE: median age 48 years (IQR 35-58), median disease duration 12 years (IQR [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] and median number of fulfilled SLE criteria 6 (IQR 5-7). Demographic variables are presented in Table 1 and the results from the selfassessments of health related quality of life (HRQoL), anxiety and depression are summarized in Table 2 .
Patients' report of symptom distress.
Twenty-three symptom categories were identified from the respondents' answers to the open questions ( Table 3 ). The three most frequently reported symptom categories were Fatigue, Pain and Musculoskeletal distress ( Table 3 ). The median number of reported categories corresponding to the question of ever-present symptoms was 3 (IQR 2-4). The patients reported fewer (p<0.001) symptom categories as being present at the time of study inclusion (median 2, IQR 1-3) compared with symptom categories reported as ever-present. A majority of the patients (n=255, 78.7%) described at least one of the top three most frequently reported symptom categories (Fatigue, Pain and Musculoskeletal distress) as being an ever-present problem.
We investigated whether patients reported the same symptoms as present at the time of study inclusion and compared this with symptoms ever experienced (Table 3 ). In half of the symptom categories the respondents did not change their answer. In six categories (Fatigue, Pain, Psychological/emotional, Cognitive, Reproduction and Sleeping disorder) over 45% of the respondents described the complaint as both an ever-present distress and as one of the presently most distressing symptoms.
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One tenth of the patients stated that they perceived no present symptom at time of inclusion in the study.
Symptom distress compared with demographic data
Present symptoms were further evaluated by comparing patients who reported a specific symptom with patients who did not report a specific symptom. The reporters in each symptom category were also compared in relation to age, disease duration and partner status. 
Symptom distress compared with disease characteristics
The symptom categories were further analyzed for disease activity, disease duration and organ damage (Table 4) 
Symptom distress compared with measurements of anxiety, depression and HRQoL
Each category was subsequently compared with results from the anxiety, depression (Table 4) and HRQoL self-assessment questionnaires (Table 5 and 
DISCUSSION
In the responses to the open-ended questions over 75% (n=255) of the SLE patients reported Fatigue, Pain or Musculoskeletal distress as the most difficult symptoms. Only patients reporting fatigue scored lower on both mental and physical aspects of HRQoL. Other symptom categories showed statistically significant impact on either the mental or the physical components of HRQoL. Noteworthy, 10% of the patients reported that they perceived no SLE symptom at the time of study inclusion. This latter finding is consistent with the finding that these patients also had lower disease activity and higher HRQoL. In recent years there has been several improvements in the treatment of patients with SLE (33, 34) , but the new therapies do not appear to have changed the fact that fatigue and pain are still perceived as the most distressing symptoms. Our results emphasize the need for further support and interventions to recognize and ease symptom load and thus improve the HRQoL 14 of patients with SLE. Further, the results indicate that the need is particularly urgent for patients with symptoms of pain or fatigue.
To our knowledge, this is the so far largest cohort study focusing on patients' self-report of SLE-related symptoms which provided us with data representing a heterogenic variation of patient-reported distress. The results are based on data from only one cohort, which calls for caution concerning the generalizability. However, the results from our study are strengthened by similarities to the symptoms identified in other studies (7, 20) . In the study of Grootscholten et al 89% of the patients reported fatigue, 61% painful joints and 54% painful muscles (7). Their symptom category "loss of concentration" (reported by 54%) has similarities to our category Cognitive distress (reported by 5%). Their result presented the highest scores for perceived burden of single symptoms as related to fatigue but also sensitivity to sunlight and disturbed memory. At least six of our categories were not clearly described in the lupus specific symptom checklist (7) (Kidney function, Reduced physical capacity, Fever, Infections, Treatment/examination, Forced adaptation or dependence).
Stamm et al (4) used the World Health Organization's International Classification of
Functioning, Disability and Health (ICF) as a framework to sort "concepts of importance" collected from persons with SLE. The authors pointed out that environmental factors are not covered by standard measures suggested for SLE (35) and specifically mentioned medication to be an environmental factor. Our symptom category distress related to Treatment/examination could be considered as such an environmental factor reported by patients as having distressing impact. In future studies it would be informative to compare patients' reports of symptoms with nursing diagnostic terms (e.g., the North American Nursing Diagnosis Association, NANDA) (www.nanda.org).
Patients reporting Fatigue and Pain in the present study scored lower than non-reporting patients on self-assessments of HRQoL. This finding is consistent with previous studies showing that pain and fatigue influenced HRQoL in patients with SLE (3, 36) . Fatigue and pain are thus well-known symptoms that need more attention if we strive to improve the care of patients with SLE. It is possible that we would have obtained similar results using SLE specific instruments such as SLEQOL or LupusQoLto assess HRQoL (37, 38) but at the time for data collection they were not available in Swedish. Also, an approach using pre-defined answers would not have allowed us to explore spontaneous answers from the informants.
In clinical care as well as in research, attention must be paid to how questions are posed to patients. It was previously demonstrated that physicians only detect 62% of the most important health outcomes in SLE as reported by individual patients (39) . Our approach with open questions without fixed answer alternatives reflects the patient's experiences of symptoms. This approach makes it possible to enlighten and detect problem areas neglected by physicians, but crucial to the individual patient. A potential limitation of our study is that the results are dependent on how the respondents interpret the questions. Interpretations are based on the patients' knowledge, individual perception and personal thoughts of their disease-related distress. A previous study has shown a discrepancy between patients and physicians' selection of important health and symptom outcomes (39) . This discrepancy has also been illustrated in the fact that even when physicians incorporate aspects of what patients tell them, a discrepancy was found between patients and physicians assessment of disease activity (40) . When evaluating disease activity, patients are influenced by their psychological and physical well-being. Physicians, on the other hand, score disease activity based on the clinical and physical signs and symptoms of lupus (41, 42) . It is however important to recall that some patient reported symptoms are manifestation of active disease, and is therefore not 
